CV vs MELI · rev $13.6M vs P/E 43, rev $19.01B
CapsoVision, Inc. Common Stock (CV) versus MercadoLibre Inc. (MELI) — a side-by-side from cached financials, not a winner call.
CapsoVision, Inc. Common Stock (CV) is a medical devices company listed on US.
MercadoLibre Inc. (MELI) is a internet retail company listed on NASDAQ.
Latest reported CV revenue for 2025-12-31 was $13.6M. Net income was -$25.3M. Revenue was up 15.3% from 2024-12-31 to 2025-12-31. CV currently screens at market cap $359.2M.
Latest reported MELI revenue for 2026-06-30 was $19.01B. Net income was $883.0M. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
CV currently screens at market cap $359.2M. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
Not investment advice. Open the CV and MELI stock pages for the full models.
Not investment advice.